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ABSTRACT
Eukaryotic DNA replication initiates at origins of
replication by the assembly of the highly conserved
pre-replicative complex (pre-RC). However, exact
sequences for pre-RC binding still remain unknown.
By chromatin immunoprecipitation we identified
in vivo a pre-RC-binding site within the origin of
bidirectional replication in the murine rDNA locus.
At this sequence, ORC1, -2, -4 and -5 are bound in
G1 phase and at the G1/S transition. During S phase,
ORC1 is released. An ATP-dependent and site-
specific assembly of the pre-RC at origin DNA was
demonstrated in vitro using partially purified murine
pre-RC proteins in electrophoretic mobility shift
assays. By deletion experiments the sequence
required for pre-RC binding was confined to 119
bp. Nucleotide substitutions revealed that two 9 bp
sequence elements, CTCGGGAGA, are essential for
the binding of pre-RC proteins to origin DNA within
the murine rDNA locus. During myogenic differen-
tiation of C2C12 cells, we demonstrated a reduction
of ORC1 and ORC2 by immunoblot analyses. ChIP
analyses revealed that ORC1 completely disappears
from chromatin of terminally differentiated myo-
tubes, whereas ORC2, -4 and -5 still remain
associated.
INTRODUCTION
The initiation of DNA replication in eukaryotic cells is
strictly coordinated within the cell cycle and starts from
discrete sites deﬁned as origins of replication. In the
budding yeast Saccharomyces cerevisiae the hexameric
origin recognition complex (ORC) binds to the origin in
an ATP-dependent manner and serves as a recruitment
factor for sequential loading of CDC6, CDT1 and
minichromosome maintenance (MCM) proteins 2–7 to
form the pre-replicative complex (pre-RC) in the early G1
phase of the cell cycle. Transition to S phase is initiated
by activation of speciﬁc protein kinases and is marked
by the conversion of pre-RCs to initiation complexes (1,2).
Although most of what we know about initiation of DNA
replication derives from studies using S. cerevisiae, the
basic composition of core initiation proteins has been
conserved among all eukaryotic organisms examined thus
far (1,3,4).
In yeast, the ORC remains bound to origin DNA
throughout the cell cycle. In higher eukaryotes, however,
the association of the ORC with chromatin seems to be
cell cycle regulated. In human cells, ORC1 dissociates
from chromatin in S phase, whereas ORC2 remains bound
(5). Likewise, hamster ORC1 is released from chromatin
as cells enter S phase and is re-bound to chromatin during
M to G1 transition (6,7). CDC6 is bound to chromatin in
G1 phase in yeast and mammalian cells. As cells enter
S phase, CDC6 is ubiquitinated and degraded in yeast
(8–10) whereas mammalian CDC6 is phosphorylated,
translocated to the cytoplasm and degraded in mitosis in
an ubiquitin-dependent manner (11,12). The activity of
CDT1 is essential for CDC6-dependent recruitment of the
MCM proteins (13,14). Hence, CDT1 accumulates during
G1 phase and is inactivated after onset of S phase
to prevent re-replication (15–17). Mammalian MCM
proteins associate with chromatin during G1 phase
(11,18–20), after the G1/S transition human MCM
proteins are progressively released (11).
During vertebrate ontogenesis, cells can exit the cell
cycle early in G1 phase and enter a quiescent (G0 phase) or
terminally diﬀerentiated state (21). It has been proposed
that the reduction of proteins involved in DNA replication
might contribute to this process (22). For instance,
MCM2-7 are depleted both in G0 phase and permanently
arrested cells. CDC6 also seems to be reduced in these
cells. However, levels of ORC proteins appear to remain
high during progression into quiescence (2).
In contrast to the conserved mechanism of initiation, the
process that determines origin selection is highly divergent.
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consensus elements (23). Metazoan origins, however, are
less speciﬁed and can probably extend over thousands of
base pairs. So far about two-dozen metazoan origins have
been described, but they do not share any consensus
sequences (24–26). Even so, sequence-speciﬁc and ATP-
dependent binding of Drosophila melanogaster ORC
has been observed at a control element in the chorion
ampliﬁcation loci (27). Three described human origins,
including the lamin B2 origin, the origin in the PRKDC/
MCM4 intergenic region, and that in the region upstream
of the human TOP1 gene have been shown to interact with
the ORC in vivo (5,28,29). However, it has also been shown
that ORC exhibits sequence-independent DNA binding.
For instance, puriﬁed human ORC binds preferentially to
synthetic AT-rich polynucleotides, but does not discrimi-
nate between natural DNA fragments with an origin and
control fragments (30). Another work demonstrated that
mammalian ORC binds to an extrachromosomally repli-
cating plasmid in a sequence-independent manner (31).
Even if it is commonly accepted that DNA replication
initiates at speciﬁc sites, it is not clear whether speciﬁc
consensus sequence elements are used to specify origins or
whether higher order regulation, like chromatin organiza-
tion, is more important.
As an experimental system to explore the initiation of
DNA replication we used murine rRNA genes.
Approximately 400 tandemly repeated rDNA units, each
44 kb in size, are clustered in the nucleolar organizing
regions of mouse cells. In the murine rRNA genes, one
origin of bidirectional replication (OBR) was mapped by
nascent strand length determination within a 3 kb region
centered  1.6 kb upstream of the rDNA transcription
start site of RNA polymerase I (32).
In this report, we identiﬁed by chromatin immunopre-
cipitation (ChIP) assays in vivo a pre-RC-binding site in
the OBR of the murine rDNA cistron. At this site, ORC
subunits 2, 4 and 5 are bound throughout the cell cycle
whereas ORC1 assembles in a cell cycle-dependent
manner. By electrophoretic mobility shift assays
(EMSA) with partially puriﬁed nuclear extracts this
binding site was conﬁrmed and conﬁned to a 119 bp
DNA sequence. A protein complex containing ORC2
showed site-speciﬁc and ATP-stimulated DNA binding.
Nucleotide substitutions in two 9 bp sequence elements
within the 119 bp pre-RC assembly site reduced the
formation of this DNA/protein complex signiﬁcantly.
We further demonstrated by immunoblot analyses the loss
of speciﬁc pre-RC proteins during myogenic diﬀerentia-
tion of C2C12 cells. ChIP analyses revealed that ORC1
is lost from the pre-RC-binding site during terminal
diﬀerentiation, but that a core complex of the pre-RC
consisting of ORC2, -4, -5, still occupies the pre-
RC-binding site in terminally diﬀerentiated myotubes.
MATERIALS AND METHODS
Cellculture andsynchronization
Murine FM3A cells were maintained at a density of 2 10
5
cells/ml in 1   RPMI-1640 medium (PAA, Austria),
supplemented with 10% fetal calf serum at 378C under
5% CO2. Cells were synchronized in G1 phase by
adding mevastatin (10 mM, ﬁnal), at the G1/S transition
by adding mimosine (0.5mM, ﬁnal) and in S phase by
adding hydroxyurea (1mM, ﬁnal) for at least 30h. The
synchronization in cell cycle was checked by propidium
iodidestainingofthecellsfollowedbyﬂowcytometryusing
FACScan analysis. Analysis was carried out on a BD LSR
System (Becton-Dickinson) and cell cycle phases were
estimated using the MultiPlus software (Phoenix Flow
Systems). Data are presented as histograms showing
relative DNA content (x-axis) and cell number (y-axis).
Mouse C2C12 myoblasts were maintained at subcon-
ﬂuent densities in Dulbecco’s modiﬁed Eagle’s medium
(PAA, Austria) supplemented with 10% fetal calf serum
(growth medium, GM) at 378C under 10% CO2.T o
prepare diﬀerentiated multinucleated myotubes, myo-
blasts were shifted to DMEM containing 2% horse
serum (diﬀerentiation medium, DM) when the cells
reached 70–80% conﬂuence. For the ﬁrst 12h, the
diﬀerentiation medium included 10mg/ml insulin
(Sigma), afterwards 10mM cytosine b-D-arabinofurano-
side (Ara-C, Sigma) was added to eliminate still replicat-
ing non-diﬀerentiated cells. The media were changed
every day.
Antibodies
Antibodies used in this work were generated against
individual initiator proteins by immunization of rabbit
(ORC2, ORC4, ORC5, ORC6) and sheep (ORC1) with
recombinant proteins. Polyclonal antisera were aﬃnity
puriﬁed on antigen columns. The speciﬁcity of antibodies
has been described earlier (33). As a negative control in
ChIP experiments corresponding to rabbit and sheep
preimmune sera, respectively, were used.
PCR primer pairs
Fragment A:5 0-GAA AGC AAA TCA CTA TGA AGA
G-30 (2798f), 50-GCA CAG TTA GGC ACA GTT AGG-
30 (3136r); fragment B:5 0-CCT AAC TGT GCC TAA
CTG TGC-30 (3116f), 50-CGT TCC CGA AAC TTG
TCA CC-30 (3483r); fragment C:5 0-AAT GAG TGA
GTG AAT GTG GCG-30 (3380f), 50-GTC CTC TCG
GCC TCA GAT GTA-30 (3815r); fragment D:5 0-CAC
GTG TCT CGT TTC GTT CC-30 (12361f), 50-ACA ACC
GCC CAC ACG TCT G-30 (12790r); 5."100:5 0-TAC
TTT CGT TTT TGG GTG CC-30 (3218f); 5."200:
50-GTA CGC TGC TCC GTC GTG-30 (3313f); 3."100:
50-CTC ACT CAT TCT GTC TCT CCG-30 (3389r);
3."200:5 0-ACA AAC GGT CCC CAT CGT-30 (3287r);
119 bp:5 0-ACG ATG GGG ACC GTT TGT-30 (3270f),
50-TCA CTC ATT CTG TCT CTC CGG-30 (3388r).
Numbers in parenthesis indicate the location of oligonu-
cleotides within the Mus musculus 45S pre rRNA gene
(accession number: X82564).
In vivocross-linking and nuclear extract preparation
DNA/protein cross-linking was performed by incubating
FM3A (2   10
7 per condition) with 1% (v/v) formalde-
hyde for 10min at RT under gentle agitation. The reaction
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0.125M. Cells were washed in PBS including protease
inhibitors and lysed by incubation in cell lysis buﬀer
(10mM Tris, pH 8.0, 10mM NaCl, 0.2% NP-40, 0.5mM
PMSF, 1  PI-Mix: 2mg/ml pepstatin, 2mg/ml leupeptin,
5mg/ml aprotinin) for 10min at 48C, followed by
centrifugation at 600g for 5min. Nuclei were lysed in
nuclei lysis buﬀer (50mM Tris, pH 8.1, 10mM EDTA,
1% SDS, 0.5mM PMSF, 1  PI-Mix) and incubated with
acid-washed glass beads for 40min on a shaker. The
extract was sonicated 7  for 30s each time and
centrifuged. The supernatant containing chromatin was
used for chromatin immunoprecipitation.
Chromatin immunoprecipitation assay
DNA fragments of less than 500 bp were obtained by
incubation with 45 U micrococcal nuclease S7 (Roche) per
200 mg nucleoprotein for 15min at 378C in the presence of
20mM CaCl2. Reactions were stopped by adding EDTA
(20mM ﬁnal). The extract was divided into three equal
volumes. One aliquot was removed and used in the PCR
analysis as input control. The remainder of chromatin
was diluted with IP dilution buﬀer (20mM Tris, pH 8.1,
150mM NaCl, 3mM EDTA, 0.01% SDS, 1% Triton
X-100) and incubated overnight at 48C with 10–15 mg
antibodies or preimmune sera in a ﬁnal volume of 800 ml.
Thirty microliter of protein A-Sepharose were added and
samples were incubated for 4h at 48C. Each batch of
resin was washed 5  with wash buﬀer I (20mM Tris,
pH 8.1, 150mM NaCl, 2mM EDTA, 0.1% SDS 1%
NP-40), 3  with wash buﬀer II (10mM Tris pH 8.1,
250mM LiCl, 1mM EDTA, 1% NP-40, 1%
Na-deoxycholic-acid) and 3  with TE (10mM Tris,
pH 8.0, 1mM EDTA). DNA–protein complexes were
eluted twice with 100 ml elution buﬀer (100mM NaHCO3,
1% SDS) for 10min at 378C. After RNase A treatment
(0.06 mg/ml) in the presence of NaCl (0.3M) for 30min at
378C, cross-links were reverted for 30min at 658C. DNA
was recovered by treating the samples overnight at 378C
with 0.2 mg/ml proteinase K, followed by two extractions
with phenol/chloroform and ethanol precipitation. DNA
was resuspended in 45 ml bdH2O and analyzed by PCR
with primer pairs speciﬁc for fragment A, B, C and D,
respectively. The ampliﬁcation program consisted of 2min
at 948C, followed by 32 cycles of 30s at 948C, 30s at 528C,
30s at 728C and ﬁnally 7min at 728C. PCR band
intensities were analyzed by Aida v.3.5. A sequence-
speciﬁc association of pre-RC proteins was assumed if the
PCR signals obtained by speciﬁc antibodies were stronger
than those by preimmune sera.
Preparation of nuclear extracts and proteinpurification
by cation exchange and gelfiltration chromatography
FM3A cells were washed in PBS and resuspended in hypo-
tonic lysis buﬀer (10mM HEPES, pH 7.8, 10mM NaCl,
1.5mM MgCl2,5 m Mb-mercaptoethanol, 1 PI-Mix,
1mM DTT). After the cell suspension was homoge-
nized in a Dounce homogenizer, 1/10 volume of 10  salt
buﬀer (300mM HEPES, pH 7.8, 1400mM KCl,
30mM MgCl2,5 m Mb-mercaptoethanol, 1  PI-Mix,
1mM DTT) was added. After centrifugation (24000g,
30min) the pellet containing the nuclei was resuspended
in KEP buﬀer (20mM HEPES, pH 7.9, 25% glycerol,
420mM KCl, 0.2mM EDTA, 1.5mM MgCl2,5 m M
b-mercaptoethanol, 1  PI-Mix, 1mM DTT) and rotated
for 1h at 48C. After centrifugation (12 000g, 30min) the
nuclear extract was dialyzed overnight against buﬀer H
(50mM HEPES, pH 7.5, 1mM EDTA, 1mM EGTA,
5mM Na-acetate, 10% glycerol, 5mM b-mercaptoetha-
nol, 1  PI-Mix, 1mM DTT) containing 250mM NaCl.
The dialyzed sample was ﬁrst puriﬁed on a 5ml cation
exchange column (HiTrap Heparin HP, Amersham
Biosciences) and bound proteins were eluted with a
linear gradient of NaCl (250–800mM). Samples were
analyzed on immunoblots for the presence of ORC2.
Fractions containing ORC2 were combined and dialyzed
overnight against buﬀer H containing 100mM NaCl.
The extract was further puriﬁed by chromatography over
a 1ml cation exchange column (HiTrap SP Sepharose
Fast Flow, Amersham Biosciences) and bound proteins
were eluted with a linear gradient of NaCl (100–
500mM). After immunoblot analysis using antibodies
against ORC1 and -2 fractions containing ORC1 and
ORC2 were concentrated on Centrifugal Filter Devices
(Amicon Ultra, Millipore) and subjected to gel ﬁltration
on a Superdex 200 PC 3.2/30 column (Amersham
Biosciences).
Electrophoretic mobility shift assay
Oligonucleotides were labeled with g
32P-ATP using T4
polynucleotide kinase. PCR reactions were carried out as
described above. EMSAs (10ml) contained 10mM
HEPES, pH 7.5, 5mM MgCl2, 1mM CaCl2,7 0 m M
KCl, 250 ng poly dI+dC, 5mM ATP (as indicated),
10 fmol g
32P-ATP 50 end-labeled DNA fragments and 400
ng puriﬁed nuclear extract. Binding reactions were
incubated for 45min on ice, 10min at 308C, and again
45min on ice. For supershift assays, 100 ng of either
speciﬁc or control antibodies were added for a further 2h
on ice. Electrophoresis was performed on 4% native
polyacrylamide gels at 100V in 0.5  TBE and at 48C.
Following electrophoresis, gels were dried and
autoradiographed.
Site-directed mutagenesis
The PCR mixture contained 20 ng template plasmid DNA
(1545 bp rDNA fragment from  3476 to  1931 cloned
into pUC18), 15 pmol of each oligonucleotide, 200mM
dNTPs, 2.5 U Pfu DNA polymerase (Stratagene) and
buﬀer in a total volume of 50ml. PCR was performed
under the following conditions: denaturation at 958C for
30s, followed by 18 cycles of 958C for 30s, 558C for 1min
and 728C for 1.5 min/kb. The reaction was incubated
with 10 U of DpnI for 1h at 378C to digest methylated,
non-mutated parental DNA. An aliquot (1/5) of the PCR
product was transformed in 100ml of competent JM109
Escherichia coli cells (Stratagene). The presence of the
mutation was conﬁrmed by DNA sequencing of the
constructs.
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BrdU staining was performed with proliferating or
diﬀerentiated C2C12 cells grown on coverslips.
In principle, BrdU was added to cell media at 10mM for
3h. After ﬁxation with 70% ethanol (30min), cells were
incubated in 0.07N NaOH for 2min followed by a
neutralization step with PBS, pH 8.5. Subsequently, cells
were incubated with anti-BrdU (Becton Dickinson) in PBS
containing 0.5% Tween 20 for 30min.
Immunoblotting analysis
Extracts from proliferating and diﬀerentiating C2C12 cells
were prepared by the following method. Cells were
trypsinized and washed twice with PBS. Cells were lysed
in cell lysis buﬀer (20mM HEPES/NaOH, pH 7.9, 10mM
NaCl, 3mM MgCl2, 0.1% NP40, 10% glycerol, 0.2mM
EDTA, 1  PI-Mix, 1mM DTT) for 15min on ice. After
centrifugation (2000 r.p.m., 5min) the soluble supernatant
was transferred to another tube and the pellet containing
the nuclei was washed once (20mM HEPES/NaOH,
pH 7.9, 20% glycerol, 0.2mM EDTA, 1  PI-Mix, 1mM
DTT). Nuclear proteins were extracted with high salt
buﬀer (20mM HEPES/NaOH, pH 7.9, 400mM NaCl,
0.2mM EDTA, 40% glycerol, 1  PI-Mix, 1mM DTT)
for 45min on ice. Protein concentrations were determined
by the method of Bradford (1976). Equal amounts (20mg)
of soluble and nuclear extract were subjected to
SDS-PAGE and transferred onto nitrocellulose membrane
(Schleicher & Schuell). The membrane was probed with
primary antibodies followed by a secondary antibody
conjugated with horseradish peroxidase and detected by
the ECL system (Amersham Bioscience).
RESULTS
APre-RC-binding site is locatedwithin the originof
bidirectional replication of themouse ribosomal genecluster
In a previous study, we have mapped an origin of
bidirectional replication (OBR) in the murine rDNA
locus by nascent strand determination analysis
(Figure 1A) (32). Since replication is initiated within a
region of 3 kb, we examined by ChIP assays whether ORC
proteins are site-speciﬁcally assembled within this OBR.
In asynchronously growing FM3A cells, proteins were
cross-linked in vivo to DNA by formaldehyde and
nucleoprotein complexes were immunoprecipitated with
antibodies raised against ORC2 as well as with preimmune
serum as a control. Precipitated DNA was ampliﬁed via
PCR using primer pairs each ﬂanking 1 kb of the OBR.
A sequence-speciﬁc association of ORC2 proteins was
assumed if the signals of PCR analyses obtained by
speciﬁc antibodies exceeded those by preimmune sera.
In ﬁrst experiments, ORC2 was found cross-linked with
DNA sequences located  3t o 2 kb upstream of the
transcription start site (data not shown). To further
conﬁne this binding site, three subfragments of this
region were used in subsequent ChIP experiments
(Figure 1A, fragments A:  2837 to  2499, B:  2519 to
 2152 and C:  2255 to  1820). PCR analysis following
immunoprecipitation with antibodies against ORC2 pro-
duced a strong signal with primer pairs for fragment B,
whereas intensities of PCR products A or C were signi-
ﬁcantly weaker (Figure 1B). This suggests that a pre-RC
binding site is located within fragment B, situated  2519
to  2152 upstream the transcription start site. As an
additional negative control, PCR analyses were performed
with primers speciﬁc for a region in the 5.8S rRNA gene,
fragment D. ORC2 was not to be found interacting with
this DNA sequence in the coding region.
Cell cycle-dependent binding ofpre-RC proteins
in murineFM3A cells
To study the binding of initiator proteins to fragment B in
the murine rDNA locus during the cell cycle, ChIP assays
with synchronized FM3A cells were performed. FM3A
cells were arrested in G1 phase, at the G1/S transition and
in S phase as described in Materials and Methods section.
Cross-linked chromatin was immunoprecipitated with
antibodies against ORC1, -2, -4 and -5, respectively,
as well as with preimmune sera. During G1 phase and at
G1/S transition ORC1, -2, -4 and -5 are bound to
fragment B (Figure 2, upper and middle panel). During
S phase, ORC1 dissociates from the pre-RC-binding site
(Figure 2, lower panel). Densitometric values of PCR
results are shown in Supplementary Figure 1. Apparently,
fragment B has an intrinsic, unspeciﬁc protein-binding
capacity resulting in a higher intensity of PCR bands with
control antibodies and primer pair B compared to primer
pairs A, C or D.
Isolated pre-RC proteins associate withorigin DNA in vitro
In order to further verify the speciﬁcity of the pre-
RC-binding site at fragment B, we performed EMSAs
with partially puriﬁed nuclear extract and the DNA
fragments described above. Proteins from FM3A nuclear
extracts were fractionated by three successive chro-
matographic steps as described in Materials and
Methods section.
To analyze the DNA-binding activity, puriﬁed proteins
of >300 kDa mass after gel ﬁltration were incubated
with radiolabeled fragment B and assayed by EMSA
(Figure 3A). Proteins of several fractions bind to DNA
fragment B, forming two major protein/DNA complexes
of distinct electrophoretic mobility, designated complexes
A and B, respectively. The fractions exerting the most
prominent shifts, i.e. E5 (molecular mass of >663 kDa)
and E11 (<440 kDa), were examined by immunoblotting
using various antibodies speciﬁc for components of the
pre-RC (Figure 3B). ORC1, -2, -4 and -5 were conﬁrmed
in fraction E5. Fraction E11 contained the same proteins
but at a lower level than in fraction E5. By this three-step
chromatography, ORC containing protein complexes
could be enriched from nuclear extracts. Fractions
E5 and E11 comprised highest DNA-binding activity
resulting in the formation of complex A and B,
respectively. Although the presence of pre-RC compo-
nents was demonstrated in these protein fractions,
the data could not provide conclusive evidence whether
the complexes are caused primarily by binding of pre-RC
6704 Nucleic Acids Research, 2007, Vol. 35, No. 20components to fragment B or whether they are due to the
interaction with unknown proteins.
Next, the eﬀect of ATP on the formation of complexes
A and B was examined. The presence of two ATP-binding
subunits in eukaryotic ORCs (27,34–36) lead us to expect
an ATP-dependent increase in DNA binding if complex A
or B contain these pre-RC components. The addition of
increasing amounts of ATP to fraction E5 results in a
dose-dependent increase of the formation of complex A,
not however, on the formation of complex B (Figure 4A).
This indicates that complex A, but not complex B, is
probably caused by the binding of pre-RC proteins to
origin DNA.
To prove an involvement of pre-RC proteins in the
formation of complex A more directly, we performed
supershift experiments using increasing amounts of
antibodies against ORC2, as a representative for pre-RC
components. Including ORC2 antibodies into the DNA/
protein-binding reaction led to a further retardation of the
mobility of complex A (Figure 4B), indicating that ORC2
is part of complex A. In contrast, antibodies against
ORC2 had no eﬀect on the mobility of complex B (data
not shown), again hinting to an ORC-independent
complex formation in the latter case.
Sequencespecificity of pre-RC binding
To investigate whether proteins in fraction E5 and E11
bind to fragment B in a sequence-speciﬁc manner, EMSA
studies were carried out comparing binding to DNA
fragments A, C and D (Figure 1A), both in the presence
and absence of ATP. Neither proteins in fraction E5 nor
Figure 1. Pre-RC proteins are associated with region B in the origin of bidirectional replication (OBR). (A) Scheme of the origin of replication in
murine rDNA. The transcription start site is marked as +1. OBR designates the origin of bidirectional replication mapped by nascent strand
determination analysis (32). DNA fragments used in ChIP and EMSA assays are denoted according to the nucleotide position at the 50 and at the 30
ends relative to the transcription start site. The 119 bp fragment used in EMSA experiments is marked by arrows. The conspicuous 9 bp repetitive
sequence elements are underlined. (B) Cross-linked chromatin was immunoprecipitated with antibodies against ORC2 (aORC2) and preimmune
serum (control). Isolated DNA was analyzed with primer pairs ﬂanking regions A, B, C and D, respectively. PCR products of the corresponding
chromatin samples before immunoprecipitation are shown (input).
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fraction E5 showed no signiﬁcant binding activity to
fragments C or D as well (Figure 4C, middle and right
panel). Thus, proteins of fraction E5 bind preferentially to
fragment B, suggesting that complex A is formed sequence
selectively. In contrast, complex B is formed on fragments
B, C and D indicating sequence-unspeciﬁc DNA binding
of proteins in fraction E11.
To further conﬁne the pre-RC-binding site within
fragment B, this fragment was shortened by 100 and
200 bp, respectively, either at the 30 or at the 50 end,
(Figure 1; 3.100; 3.200; 5.100; 5.200). As shown in
Figure 5A, lane 2 and 3, complex A is formed with
fragments truncated 100bp at their 30 or 50 ends. However,
if 200 bp are deleted, formation of the protein/DNA
complex is abrogated in both cases (Figure 5A, lanes 4
and 5). This indicates that a DNA sequence in the middle
of fragment B is essential for the formation of complex A.
EMSA experiments with a 119bp fragment located in the
middle of fragment B ( 2365 to  2247, see Figure 1)
showed that complex A is still formed in an ATP-
dependent manner (Figure 5A, lanes 7 and 8). Thus, this
119 bp DNA fragment is suﬃcient for pre-RC/DNA
complex formation.
Inspecting this central 119bp region closely, two
conspicuous 9bp sequence elements, CTCGGGAGA,
were observed which are repeated at intervals of 63bp
( 2343 to  2335;  2280 to  2272) and which are
completely or partially disrupted by the 200bp deletions.
To examine whether these sequence elements play a role in
formation of complex A, we altered the sequence by
introducing C to A, T to G and vice versa substitutions
using site-speciﬁc mutagenesis. Four successive substitu-
tions of 4 bp each were constructed, whereby the obtained
constructs were used as template DNA for the subsequent
mutagenesis (119.S1, 119.S2, 119.S3 and 119.S4; for
sequences, see Table 1). EMSA experiments carried out
with the mutated 119 bp DNA fragments showed that
substitutions 1 (119.S1; lanes 9 and 10), 2 (119.S2, lanes
11 and 12) and 3 (119.S3, lanes 13 and 14) did not aﬀect
formation of the DNA/protein complexes. However, if
8 out of 9 bp in both sequence elements (119.S4) are
substituted, formation of complex A is signiﬁcantly
reduced (lanes 15 and 16) indicating that the
CTCGGGGAGA sequences might inﬂuence binding of
pre-RC proteins to DNA in the murine rDNA locus.
Interestingly, a naked DNA fragment containing all four
Figure 3. Puriﬁcation and analysis of proteins from murine nuclear
extracts. (A) Nuclear extracts from FM3A cells were puriﬁed twice on
cationic exchange columns and once by gel ﬁltration on a
Superdex
TM200 10/300 GL column, calibrated with thyroglobulin and
ferritin. To test for DNA-binding activity aliquots of fractions E4 to
E15 were subjected to EMSA with 10 fmol g
32P-ATP 50 end-labeled
fragment B in the presence of 5mM ATP and 250 ng poly dI+dC.
Protein/DNA complexes A and B are indicated. (B) Immunoblot
analysis of fractions E5 and E11 with antibodies raised against ORC1,
-2, -4 and -5, respectively.
Figure 2. Sequence-dependent association of pre-RC proteins with the
OBR throughout the cell cycle in vivo.( A) FACS analyses showing cell
cycle arrest of FM3A cells in G1 phase (82.6%), at the G1/S boundary
(82.8%) and in S phase (66.8%). (B) Synchronized FM3A cells were
treated with formaldehyde, cell lysates were prepared and subjected to
immunoprecipitation using antibodies against ORC1, -2, -4 and -5 or
using preimmune sera (control). Representative results of three
experiments are shown.
6706 Nucleic Acids Research, 2007, Vol. 35, No. 20substitutions (Figure 5B, 119.S4) migrates distinctly
slower than protein-free WT 119 and 119.S1–119.S3
(lanes 1–4 and 6) suggesting that the secondary structure
of the DNA is altered as a result of the S4 nucleotide
substitutions.
Taken together, we were able to reproduce in vitro by
EMSA the sequence-speciﬁc binding of pre-RC proteins
to DNA shown in vivo by ChIP experiments. Formation of
complex A, which contains ORC2 as conﬁrmed by
supershifting, is stimulated by ATP and occurs in a
sequence-speciﬁc manner, preferring fragment B over A,
C and D. Moreover, mutational analyses of fragment B
revealed that (i) the pre-RC-binding site is situated
within 119bp, from  2365 to  2247 upstream the
transcription start site and that (ii) two sequence elements,
CTCGGGAGA, are crucial for the binding of pre-RC
proteins to DNA.
Myogenic differentiation of C2C12cells
Recent studies on various organisms have shown that in
terminally diﬀerentiated cells or tissues some components
of the pre-RC are absent (2). The loss of pre-RC
components upon cell cycle exit could be a regulatory
mechanism to suppress cell proliferation.
To address this issue experimentally, we analyzed
protein levels of pre-RC components during myogenic
diﬀerentiation and determined whether components of the
pre-RC are attached to the OBR in terminally diﬀer-
entiated myotubes. For that we used murine C2C12 cells,
which can be induced to terminal diﬀerentiation into
myotubes by exposure to low mitogen medium for several
days. Diﬀerentiation was assessed by morphological
examination. After 5 days in diﬀerentiation medium
(DM), predominantly elongated myotubes were present
in the culture (Figure 6A, upper panel). The percentage of
S phase cells considerably decreased during myogenic
diﬀerentiation (34.4% in proliferating versus 2.4% in
diﬀerentiated cells) concomitantly with a signiﬁcant
increase in the percentage of myotubes in the G0/G1
phase of the cell cycle (54.4% in proliferating versus
95.6% in diﬀerentiated cells, middle panel). The cessation
Figure 4. DNA/protein complex A binds ATP dependently and sequence selectively to fragment B and is supershifted with antibodies against ORC2.
(A) EMSAs were performed with proteins of fractions E5 or E11 (300 ng) and g
32P-ATP 50 end-labeled fragment B with increasing concentrations of
ATP (0.5, 1, 2.5 or 5mM). (B) For supershifting, binding reactions were performed by incubating g
32P-ATP 50 end-labeled fragment B and proteins
of fraction E5 in the presence of 5mM ATP with increasing amounts of antibodies against ORC2 as indicated. (C) EMSAs were performed with
proteins of fractions E5 or E11 and fragments A, C and D in the absence or presence of 5mM ATP.
Nucleic Acids Research, 2007, Vol. 35, No. 20 6707of DNA replication in myotubes could further be veriﬁed
by BrdU incorporation. After ﬁve days in diﬀerentiation
medium only two persisting myoblasts were replicating in
the examined area (lower panel).
Thus, a system of terminally diﬀerentiated cells was
available to investigate the expression of pre-RC compo-
nents during diﬀerentiation and their interaction with the
OBR region in terminally diﬀerentiated myotubes.
Expression of pre-RC proteins during myogenic
differentiation ofC2C12 cells
Immunoblot analyses were performed with nuclear and
soluble extracts, respectively, prepared from proliferating,
conﬂuent or diﬀerentiating C2C12 cells. Subsequently
immunoblot analyses of pre-RC components were carried
out using speciﬁc antibodies raised against ORC1
and ORC2 (Figure 6B). Sixty hours post-diﬀerentiation,
the amount of ORC1 in the nucleus was at
undetectable levels. In contrast, soluble ORC1 levels
exhibited a peak at 84h and were then reduced. ORC2
expression remained unaﬀected until 60h, and even after
132h ORC2 was detectable at low levels in the nucleus.
A soluble variant of ORC2 migrating slower than nuclear
ORC2 was observed during diﬀerentiation, probably due
to phosphorylation. Immunoblot analysis of proliferating
cell nuclear antigen (PCNA) demonstrated nuclear
localization exclusively in proliferating myoblasts, not
however, in diﬀerentiated myotubes. A slow reduction of
soluble PCNA with complete disappearance after 132h in
DM was observed.
In summary, protein levels of ORC1 and ORC2
signiﬁcantly decreased in murine C2C12 myotubes
during diﬀerentiation. ORC1 could hardly be detected in
Figure 5. The pre-RC-binding site is conﬁned to a 119 bp region of fragment B. (A) EMSAs analyses with deleted fragment B (3.100, 5.100,
3.200, 5.200; see Figure 1A) and wild-type or mutant 119 bp fragments (119, 119.S1–S4). Sequences of the mutant constructs are given in Table 1.
(B) Migration of protein-free 119 bp DNA fragments, WT and S1 to S4, in a 4% PAA gel.
Table 1. Sequences of the mutated 119 bp fragments
119
(original sequence)
50-ACGATGGGGACCGTTTGTGCCACTCGGGAGAAGTGGTGGGTGG GTACGCTGCTCCGTCGTGCGTGCGTGA
GTGCCGGAACCTGAGCTCGGGAGACCCTCCGGAGAGACAGAATGAGTGA_30
119.S1 50-ACGATGGGGACCGTTTGTGCCAAGATGGAGAAGTGGTGGGTGG GTACGCTGCTCCGTCGTGCGTGCGTGA
GTGCCGGAACCTGAGCTC GGGAGACCCTCCGGAGAGACAGAATGAGTGA-30
119.S2 50-ACGATGGGGACCGTTTGTGCCAAGATTTCTAAGTGGTGGGTGG GTACGCTGCTCCGTCGTGCTGCGTGAG
TGCCGGAACCTGAGCTC GGGAGACCCTCCGGAGAGACAGAATGAGTGA-30
119.S3 50-ACGATGGGGACCGTTTGTGCCAAGATTTCTAAGTGGTGGGTGG GTACGCTGCTCCGTCGTGCGTGCGTGA
GTGCCGGAACCTGAGAGA TGGAGACCCTCCGGAGAGACAGAATGAGTGA-30
119.S4 50-ACGATGGGGACCGTTTGTGCCAAGATTTCTAAGTGGTGGGTGG
GTACGCTGCTCCGTCGTGCGTGCGTGAGTGCCGGAACCTGAGAGAT TTCTACCCTCCGGAGAGACAGAATGA
GTGA-30
Conspicuous sequence elements are depicted in bold letters, introduced mutations are underlined.
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was detectable, albeit at lower levels than in proliferating
myoblasts. These data demonstrate that the loss of
proliferation capacity of mammalian cells during diﬀer-
entiation is associated with down-regulation of constitu-
ents of the pre-RC.
In vivooccupancy of theOBR region with pre-RC
proteins in terminally differentiated myotubes
We performed ChIP analyses comparing chromatin of
proliferating cells to that of diﬀerentiated cells to elucidate
if members of the pre-RC still occupy the OBR region in
non-replicating cells. Formaldehyde cross-linked nuclear
proteins of proliferating and diﬀerentiated C2C12 cells
after 5 days in DM were prepared. Chromatin was
immunoprecipitated with antibodies raised against
ORC1, -2, -4 and -5 and was analyzed with primer pairs
speciﬁc to the pre-RC assembly region (fragment B) and
to the control region in the 5.8S rRNA gene (fragment D).
Preimmune serum served as control. Densitometric values
of PCR results are shown in Supplementary Figure 2.
All investigated proteins are bound to OBR sequences in
asynchronously growing cells (Figure 6C, upper panel).
When cells exit the cell cycle during diﬀerentiation, ORC1
is released from chromatin (Figure 6C, lower panel).
ORC2, -4 and -5 remain bound to the OBR region in
terminally diﬀerentiated cells. The control region in the
5.8S rRNA gene showed no interaction with any of
these proteins.
These results probably indicate that chromatin associa-
tion of ORC1 is regulated during transition from
proliferation to terminal diﬀerentiation.
DISCUSSION
In the current work, we demonstrated that a
pre-RC-binding site is located in a region positioned
from  2519 to  2152 upstream the transcription start site
of RNA polymerase I within the OBR of the murine
rDNA gene cluster. This pre-RC-binding site has been
veriﬁed by three independent approaches. First, we
showed in vivo by ChIP experiments a cell cycle-dependent
association of pre-RC proteins with this sequence in
murine FM3A cells. Second, we demonstrated in vitro
by EMSA a sequence-speciﬁc and ATP-stimulated bind-
ing of protein complexes containing ORC proteins to
this DNA region. Deletion mutagenesis revealed that
this binding site is located within 119 bp at  2365 to
 2247 and that a repeated element, CTCGGGAGA, is
crucial for the assembly of pre-RC proteins. Third, we
showed by ChIP experiments in terminally diﬀerentiated
murine C2C12 cells that this binding site still exists, but
that only a subset of pre-RC proteins is bound at this
region in diﬀerentiated myotubes.
Figure 6. Distinct pre-RC proteins are absent in terminally diﬀerentiated myotubes. (A) Myogenic diﬀerentiation of C2C12 cells. Phase contrast
microscopy showing cultures containing terminally diﬀerentiated myotubes by day 5 in diﬀerentiation medium (DM) (upper panel). Cell cycle proﬁles
of proliferating (54.4% G1 phase, 34.4% S phase, 11.2% G2 phase) and diﬀerentiated (95.6% G1 phase, 2.4% S phase, 1.9% G2 phase) C2C12 cells
(middle panel). BrdU incorporation: representive areas examined by indirect immunoﬂuorescence microscopy demonstrate the cessation of DNA
synthesis in diﬀerentiated C2C12 cells (lower panel). (B) Immunoblot analyses of pre-RC proteins during diﬀerentiation of C2C12 cells. Nuclear (NE)
and soluble (SE) extracts were prepared from proliferating (p), conﬂuent (c) and diﬀerentiating C2C12 cells at the times indicated in diﬀerentiation
medium (DM). Same amounts (20mg) of extracts were dissolved by SDS-PAGE and immunoblot analyses were performed using antibodies raised
against pre-RC proteins. GM: growth medium. (C) ChIP analyses of pre-RC components interacting with fragment B in the OBR region in
proliferating C2C12 myoblasts or terminally diﬀerentiated C2C12 myotubes after ﬁve days in DM. ChIP analysis was performed as described above
with the antibodies indicated. Representative results of three experiments are shown.
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tofragment B
Using synchronized FM3A cells, we demonstrated that an
ORC core complex consisting of ORC 2, -4, -5 was stably
bound to fragment B throughout the cell cycle, whereas
ORC1 exhibited a cell cycle-dependent association.
During G1 phase and at the G1/S transition, ORC1, -2,
-4 and -5, were bound to fragment B. In S phase, ORC1
dissociated from the initiation complex.
Compared to yeast and Drosophila, where ORC
remains associated with chromatin throughout the cell
cycle (37–39), ORC binding in mammalia is cell cycle-
dependent. The association patterns we observed in
murine cells are similar to those described for other
species. In hamster cells, ORC1 is released from chromatin
as cells enter S phase and is re-bound to chromatin during
M to G1 transition (6,7). Similarly, we found that murine
ORC1 is bound to chromatin in G1 and at the G1/S
transition, but not in S phase. Furthermore, we demon-
strated that ORC2 remains bound to chromatin through-
out the cell cycle. In a recent study, it was shown also
that human ORC1 and -2 bind at an origin of DNA
replication in G1 phase but in S phase only ORC2 remains
bound (5).
The pre-RChas an intrinsic sequence-selective
DNA-binding activity
We have demonstrated that puriﬁed nuclear extracts
containing ORC proteins bind ATP dependently and
sequence speciﬁcally to fragment 119. The question arises
why this sequence is preferred compared to adjacent
sequences.
A possibility for ORC to ﬁnd its binding site is the
presence of ancillary factors promoting chromatin bind-
ing. It has been proposed that CDC6 might reduce the
aﬃnity of ORC to non-speciﬁc DNA and therefore acts as
an essential determinant for origin speciﬁcity in metazoans
(40,41). In the case of Epstein-Barr virus, the viral
transcription factor EBNA-1 binds ORC and may be
involved in the recruitment of ORC to oriP (42). It is
highly probable that we copuriﬁed CDC6 or a yet
unknown protein, which directs ORC to its binding site
and that ORC itself is not responsible for sequence-
speciﬁc binding to fragment B. The identiﬁcation of all
proteins involved in the formation of the DNA/protein
complexes by mass spectrometry would be very interesting
and remains to be done.
We conﬁned the pre-RC-binding site to 119 bp within
fragment B and found that a repetitive 9 bp sequence
element, CTCGGGAGA, plays a crucial role in ensuring
eﬃcient loading of pre-RC proteins to DNA. In contrast
to yeast where the ORC binds to deﬁned sequences called
ARS, origins in higher eukaryotes do not appear to
contain consensus sequences, although some origins
include AT-rich sequences (43). Fragment 119, however,
is not particularly AT-rich, since its AT content is only
37% and no AT-rich nucleotide clusters are to be found.
By substitutions S1–S4, the AT content is stepwise
increased. On S4, the fragment with the highest AT
content (44%), nearly no binding of pre-RC proteins was
observed. We therefore propose that a higher AT content
is not essential for ORC–DNA interaction within frag-
ment 119.
If the 9 bp elements represent a consensus binding
site for pre-RC proteins or for ancilliary factors recruiting
pre-RC proteins to origin DNA, these elements are to be
found in other origin regions. However, these elements
could neither be detected with 100% identity in the
origins of the human MCM4/PRKD (U90415), TOP1
(AL035652) and Lamin B2 (M94363) genes nor in the
Sciara puﬀ II/9A origin (AF332610). In the TOP1 gene
two sequences with 88.8% (CTGGGGAGA) and 77.7%
(CTCCGGAGT) and in the MCM4/PRKD gene with
77.7% (CCCGGGAAA) and 66.6% (CCTCCCGGA)
identity, respectively, were found. However, these ele-
ments are 588 and 620 bp, respectively, apart from each
other, and hence are located at a greater distance
compared to those in the murine rRNA genes.
Interestingly, the distance of 63 bp between both sequence
elements corresponds to six helical turns of B DNA
(10.5bp/helical turn). Intrinsically bent or curved DNA
molecules result when distinct base sequences or structural
motifs are repeated in phase with the DNA helical repeat
(44). Signiﬁcantly, substitution 4 within the 9 bp sequence
element leads to a slight, but measurable decrease of
the relative electrophoretic mobility of the naked DNA,
indicating an altered secondary structure as a result of
substitution S4. Therefore, the 9 bp sequence element
probably does not constitute a consensus binding
sequence per se, but rather has eﬀects on the formation
of speciﬁc secondary DNA structures, which could allow
binding of the pre-RC or its recruitment factor to this
region of the murine rDNA.
Remarkably, the 9 bp sequence element is to be found a
third time within the 119 bp fragment ( 2269 to  2261:
CTCCGGAGA) with 88.8% identity and inverted
CTCGGGAGA elements are found three times in the
murine rRNA genes on the coding (+1794 to +1802:
AGAGGGCTC) and non-coding strand (+11238 to
+11246: TCTCCCGAG; +12980 to +12988:
TCTCCCGAG). It has been described that more active
initiation sites exists in the murine rDNA located
either between + 2.0 and 8.0 kb or approximately at
+13kb downstream of the transcription start site (32).
Interestingly, an ORC2-binding site was localized by ChIP
in the region from +1642 to +2082 including one of the 9
bp sequence elements described above (unpublished data).
Also, in the region  +13 kb an inverted CTCGGGAGA
element was found on the non-coding strand. However,
so far this region has not been studied in respect of pre-
RC-binding sites. Since pre-RC proteins exhibited rela-
tively weak binding to fragment B in vitro, attempts to
detect a speciﬁc DNA sequence by DNase I footprint
experiments were unsuccessful (data not shown). Despite
the sequence-speciﬁc binding of pre-RC proteins to
fragment 119 and the evidence that the 9 bp sequence
elements play a crucial role in this process, it is possible
that the in vivo binding of pre-RCs to origins might be
6710 Nucleic Acids Research, 2007, Vol. 35, No. 20additionally aﬀected by surrounding DNA sequences,
by chromatin structure or by epigenetic events.
Initiation proteins interminally differentiated cells
As cells undergo terminal diﬀerentiation, they enter an
irreversible cell cycle arrest and generally lose the capacity
to go through DNA replication and cell division.
In previous studies, it has been proposed that the absence
of proteins involved in initiation of DNA replication in
quiescent or diﬀerentiated cells seems to be crucial for the
maintenance of the ‘out-of-cycle’ state (22). To investigate
the fate of replication proteins upon cell cycle exit, we
took advantage of the in vitro diﬀerentiation of murine
C2C12 myoblast cells to myotubes. These cells undergo
terminal diﬀerentiation when exposed to a low mitogen
medium. Using immunoblot analysis we demonstrated
that ORC1 and -2 were abundant in proliferating cells,
but the levels of these proteins were reduced after cells
underwent diﬀerentiation. The reduction of ORC1 and
-2 levels during diﬀerentiation is in agreement with a
previous report showing that ORC1 and -2 are lacking in
terminally diﬀerentiated Xenopus erythrocytes (45). ORC1
was reduced notably faster than ORC2, which suggests
that ORC1 might be the limiting component of the active
murine pre-RC. This is aﬃrmed by the fact that during
normal cell cycle transit the activity of ORC1, as the only
ORC subunit, is regulated by ubiquitination. This
modiﬁcation results either in degradation of human
ORC1 (11,46–48) or in dissociation of ORC1 from
chromatin in hamster cells (6). In a similar manner, the
degradation of ORC1 in terminally diﬀerentiated cells
might contribute to the maintenance of the postmitotic
state. Contrary to studies showing that ORC2 levels
remain unaﬀected in human diﬀerentiated or quiescent
cells (22,49,50) we observed that levels of ORC2 were
reduced, but did not completely disappear, during
terminal diﬀerentiation of murine C2C12 cells. A slower
migrating soluble variant of ORC2 was observed in the
course of diﬀerentiation, probably a result of phosphor-
ylation. In S. cerevisiae (51), S. pombe (52) and Xenopus
laevis (53) ORC2 is phosphorylated by CDK/cyclin
complexes. The phosphorylation might result in confor-
mational changes within the ORC and thereby probably
inhibits binding of additional factors and prevents
re-replication (54–56). ChIP experiments revealed that
ORC1 dissociated from the pre-RC-binding site during
diﬀerentiation, whereas ORC2, -4 and -5 were still bound
to the OBR. The loss of ORC1 from chromatin in
terminally diﬀerentiated cells is in agreement with the fast
reduction of ORC1 shown by immunoblotting and could
explain the function of this protein as regulator of the
initiation of DNA replication in proliferating cells. Since
ORC2 was present in the nucleus of myotubes at a very
low level, but was detected by ChIP experiments at the
OBR, this suggests that a persisting fraction of ORC2
remains bound at origins previously used in proliferating
cells. This observation could also imply that ORC2 is not
yet fully degraded upon diﬀerentiation and that soluble
ORC2 is reduced ﬁrst and chromatin-bound ORC2 later.
ORC4 and -5 remain bound to chromatin in diﬀerentiated
cells. Formerly, it was also demonstrated that Orc2,
-3 and -5 can be detected in non-proliferating human
cells (50). Alternatively, the persistence of ORC subunits
in non-cycling cells could be due to the fact that despite
their function in initiation of DNA replication these
proteins play additional roles, for example in transcrip-
tional silencing (39,57,58).
Taken together, the reduction and the chromatin
dissociation of several proteins involved in the events of
initiation of DNA replication could be demonstrated
during myogenic diﬀerentiation of C2C12 cells. The loss
of the important regulatory initiation protein ORC1 in
terminally diﬀerentiated cells might contribute to the
establishment and maintenance of the ‘out-of-cycle’ state,
as a part of a highly sophisticated and regulated network.
Nevertheless, the function of pre-RC proteins remaining
at the OBR in terminally diﬀerentiated C2C12 cells
remains unknown.
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